Two undergraduate medicine students at University of Galway have led a major study examining how cardioprotective glucose-lowering therapies—medications that lower blood sugar and reduce the risk of heart disease in people ...
Apr 8, 2025
0
1
Most older adults prioritize retaining the ability to bathe, dress, walk, and perform household tasks independently as they age. Yet much is yet to be understood about the causes of disability among this age group. In a new ...
Apr 8, 2025
0
1
A Boston Children's Hospital study uncovers how fetal magnetic resonance imaging (MRI) could be a game-changer in predicting outcomes for infants born with vein of Galen malformations (VOGMs).
Apr 8, 2025
0
0
New research from Weill Cornell Medicine has uncovered a surprising culprit underlying cardiovascular diseases in obesity and diabetes—not the presence of certain fats, but their suppression. The study, published Feb. 25 ...
Apr 8, 2025
0
31
A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of drugs originally developed to treat lymphomas and related blood disorders, demonstrated a 31% delay ...
Apr 8, 2025
0
34
"Avoid screens before bed" is one of the most common pieces of sleep advice. But what if the real problem isn't screen time—it's the way we use social media at night?
Apr 8, 2025
0
1
A deadly disease is on the rise: dengue, a mosquito-borne virus that already affects millions and is spreading even further due to climate change. Despite its growing threat, dengue is hard to study in animals—and even ...
Apr 8, 2025
0
34
Poor dietary habits in adolescence—lots of sweets, sugary drinks or skipping breakfast—is directly linked to overusing social media, University of Queensland research has found.
Apr 8, 2025
0
0
Older individuals who struggle to chew hard food have a higher risk of becoming malnourished or experiencing significant weight loss over time. This is shown in a new Swedish population-based study by researchers at Karolinska ...
Apr 8, 2025
0
0
Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials for the treatment of amyotrophic lateral sclerosis (ALS)—improves neuron health in animal models ...
Apr 8, 2025
0
32
